India, Feb. 20 -- This Mid-cap Pharma Stock, engaged in manufacturing and marketing branded generics, APIs, nutraceuticals, and biosimilars across acute and chronic therapies globally, is in focus after Jefferies gave a target of Rs. 6,550, which has an upside potential of 21.86 percent.

With a market capitalization of Rs. 64,266.19 crore, the shares of Alkem Laboratories Limited were currently trading at Rs. 5,375 per equity share, rising nearly 0.01 percent from its previous day's close price of Rs. 5,374.40.

Jefferies, a prominent brokerage firm, has recommended a "Buy" call on Alkem Laboratories Limited with a target price of Rs. 6,550 per share, indicating an upside potential of 21.86 percent from its current market price.

Jeffer...